0001209191-17-066620.txt : 20171220 0001209191-17-066620.hdr.sgml : 20171220 20171220160434 ACCESSION NUMBER: 0001209191-17-066620 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171219 FILED AS OF DATE: 20171220 DATE AS OF CHANGE: 20171220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KELLOGG PETER N CENTRAL INDEX KEY: 0001226287 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 171266825 MAIL ADDRESS: STREET 1: MERCK & CO., INC STREET 2: ONE MERCK DRIVE., P.O. BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-12-19 0 0000816284 CELGENE CORP /DE/ CELG 0001226287 KELLOGG PETER N C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 0 1 0 0 See Remarks Common Stock 2017-12-19 4 M 0 3410 0.00 A 44145 D Common Stock 2017-12-19 4 F 0 1768 107.06 D 42377 D Common Stock 348 I 401(k) Plan Restricted Stock Unit 2017-12-19 4 M 0 3410 0.00 D Common Stock 3410 0 D All of the restricted stock units granted to the reporting person on December 19, 2014 vested and settled for shares of the Company's common stock. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units were issued pursuant to The Celgene Corporation 2017 Stock Incentive Plan. Executive Vice President and Chief Financial Officer Mark J. Alles, Attorney-in-Fact 2017-12-20